For: | Abdel-Hamid NM. Recent insights on risk factors of hepatocellular carcinoma. World J Hepatol 2009; 1(1): 3-7 [PMID: 21160959 DOI: 10.4254/wjh.v1.i1.3] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v1/i1/3.htm |
Number | Citing Articles |
1 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
|
2 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
|
3 |
Abdel Raouf Abou El Azm, Mohamed Yousef, Nagwa Mansour, Aymen Awad, Samia El Dardiry, Ibrahim Abdel Aziz. New Insights on Non-B non-C Hepatocellular Carcinoma in Mid Delta Region, Egypt. Journal of Gastrointestinal Cancer 2014; 45(3): 276 doi: 10.1007/s12029-013-9573-8
|
4 |
N.M. Abdel-Hamid, Dalia E. Shehata, Ahmed A. Abdel-ghany, Ahmed Ragaa, Ahmed Wahid. Serum serotonin as unexpected potential marker for staging of experimental hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2016; 83: 407 doi: 10.1016/j.biopha.2016.07.005
|
5 |
Abdel Raouf Abou El Azm, Mohamed Yousef, Raafat Salah, Wael Mayah, Salwa Tawfeek, Hussien Ghorabah, Nagwa Mansour. Serum anti-P53 antibodies and alpha-fetoprotein in patients with non-B non-C hepatocellular carcinoma. SpringerPlus 2013; 2(1) doi: 10.1186/2193-1801-2-69
|
6 |
Yusuke Kanda, Mitsuhiko Osaki, Futoshi Okada. Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction. International Journal of Molecular Sciences 2017; 18(4): 867 doi: 10.3390/ijms18040867
|
7 |
NM Abdel-Hamid, MF Ramadan, SW Amgad. Glycoregulatory Enzymes as Early Diagnostic Markers during Premalignant Stage in Hepatocellular Carcinoma. American Journal of Cancer Prevention 2013; 1(2): 14 doi: 10.12691/ajcp-1-2-1
|
8 |
Nabil M. Abdel-Hamid, Maiiada H. Nazmy, Manal I. Abdel-Ghany, Walaa H. Nazmy. Cytokines as important playmakers of experimental hepatocarcinogenesis confounded by diabetes. Annals of Hepatology 2012; 11(1): 118 doi: 10.1016/S1665-2681(19)31495-4
|
9 |
N.M. Abdel-Hamid, M.H. Nazmy, A.I. Abdel-Bakey. Polyol profile as an early diagnostic and prognostic marker in natural product chemoprevention of hepatocellular carcinoma in diabetic rats. Diabetes Research and Clinical Practice 2011; 92(2): 228 doi: 10.1016/j.diabres.2011.02.003
|
10 |
N. M. Abdel-Hamid, O. M. Mohafez, M. H. Nazmy, A. Farhan, K. Thabet. The effect of co-administration of Lawsonia inermis extract and octreotide on experimental hepatocellular carcinoma. Environmental Health and Preventive Medicine 2015; 20(3): 195 doi: 10.1007/s12199-015-0451-9
|
11 |
Nader Nemr, Mohamed Mandour, Dahlia Badran, Rania Kishk, Fawzy Attia, Abdullah Hashish, Ahmed Gaber. Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients. Bulletin of the National Research Centre 2019; 43(1) doi: 10.1186/s42269-019-0226-3
|
12 |
Aruljothi Subramaniam, Muthu K. Shanmugam, Ekambaram Perumal, Feng Li, Alamelu Nachiyappan, Alan P. Kumar, Benny K. H. Tan, Gautam Sethi. Perspectives in Cancer Prevention-Translational Cancer Research. 2014; : 73 doi: 10.1007/978-81-322-1533-2_6
|
13 |
Sara Ashtari, Mohamad Amin Pourhoseingholi, Afsaneh Sharifian, Mohamad Reza Zali. Hepatocellular carcinoma in Asia: Prevention strategy and planning. World Journal of Hepatology 2015; 7(12): 1708-1717 doi: 10.4254/wjh.v7.i12.1708
|